Dow Jones

39 856,95

0,13%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
OTR Acquisition Corporation (OTRA)
OTR Acquisition Corporation (OTRA) Actualités

OTRA

OTR Acquisition (OTRA)

OTR Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:OTRA

Date	Heure	Source	Titre	Symbole	Société
13/02/2023	19h45	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OTRA	OTR Acquisition Corporation
31/05/2022	14h01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:OTRA	OTR Acquisition Corporation
20/05/2022	22h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OTRA	OTR Acquisition Corporation
20/05/2022	14h00	Business Wire	Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics	NASDAQ:OTRA	OTR Acquisition Corporation
19/05/2022	22h08	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:OTRA	OTR Acquisition Corporation
18/05/2022	15h29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OTRA	OTR Acquisition Corporation
17/05/2022	15h55	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:OTRA	OTR Acquisition Corporation
13/05/2022	22h36	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OTRA	OTR Acquisition Corporation
13/05/2022	13h17	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:OTRA	OTR Acquisition Corporation
09/05/2022	14h00	Business Wire	Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation	NASDAQ:OTRA	OTR Acquisition Corporation
27/04/2022	14h00	Business Wire	Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo	NASDAQ:OTRA	OTR Acquisition Corporation
19/04/2022	14h00	Business Wire	Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration	NASDAQ:OTRA	OTR Acquisition Corporation
18/04/2022	14h00	Business Wire	Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination	NASDAQ:OTRA	OTR Acquisition Corporation
15/04/2022	18h05	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:OTRA	OTR Acquisition Corporation
08/03/2022	22h08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OTRA	OTR Acquisition Corporation
08/03/2022	22h02	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:OTRA	OTR Acquisition Corporation
18/02/2022	22h38	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OTRA	OTR Acquisition Corporation
04/02/2022	14h00	Business Wire	OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination	NASDAQ:OTRA	OTR Acquisition Corporation
31/01/2022	14h32	Business Wire	Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.	NASDAQ:OTRA	OTR Acquisition Corporation
06/08/2021	22h16	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OTRA	OTR Acquisition Corporation
17/05/2021	22h11	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:OTRA	OTR Acquisition Corporation